These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 19158832

  • 1. The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.
    Bruns I, Czibere A, Fischer JC, Roels F, Cadeddu RP, Buest S, Bruennert D, Huenerlituerkoglu AN, Stoecklein NH, Singh R, Zerbini LF, Jäger M, Kobbe G, Gattermann N, Kronenwett R, Brors B, Haas R.
    Leukemia; 2009 May; 23(5):892-9. PubMed ID: 19158832
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.
    Kronenwett R, Butterweck U, Steidl U, Kliszewski S, Neumann F, Bork S, Blanco ED, Roes N, Gräf T, Brors B, Eils R, Maercker C, Kobbe G, Gattermann N, Haas R.
    Oncogene; 2005 Aug 11; 24(34):5313-24. PubMed ID: 15806158
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.
    Cancer Res; 2000 Feb 01; 60(3):610-7. PubMed ID: 10676644
    [Abstract] [Full Text] [Related]

  • 7. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M, Maeda H, Hara H, Yamamoto Y, Furuyama J.
    Stem Cells; 1993 Nov 01; 11(6):536-42. PubMed ID: 7509222
    [Abstract] [Full Text] [Related]

  • 8. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A, Rosas-Cabral A, Vela-Ojeda J, González JC, Mayani H.
    Leuk Res; 2004 Jun 01; 28(6):639-47. PubMed ID: 15120942
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ, Biernacki M, Kutok JL, Rogers S, Chen L, Yang XF, Soiffer RJ, Ritz J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4504-11. PubMed ID: 15958636
    [Abstract] [Full Text] [Related]

  • 12. Characterization and selection of benign stem cells in chronic myeloid leukemia.
    Lemoli RM.
    Haematologica; 1993 Jun 15; 78(6):393-400. PubMed ID: 8175034
    [Abstract] [Full Text] [Related]

  • 13. p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells.
    Salesse S, Dylla SJ, Verfaillie CM.
    Leukemia; 2004 Apr 15; 18(4):727-33. PubMed ID: 14961028
    [Abstract] [Full Text] [Related]

  • 14. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
    Jiang X, Saw KM, Eaves A, Eaves C.
    J Natl Cancer Inst; 2007 May 02; 99(9):680-93. PubMed ID: 17470736
    [Abstract] [Full Text] [Related]

  • 15. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
    Gentil M, Hugues P, Desterke C, Telliam G, Sloma I, Souza LEB, Baykal S, Artus J, Griscelli F, Guerci A, Johnson-Ansah H, Foudi A, Bennaceur-Griscelli A, Turhan AG.
    PLoS One; 2018 May 02; 13(8):e0200923. PubMed ID: 30091999
    [Abstract] [Full Text] [Related]

  • 16. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K, Yamaguchi H, Tarusawa M, Futaki M, Hanawa H, Tanosaki S, Dan K.
    Leukemia; 2002 Feb 02; 16(2):170-7. PubMed ID: 11840282
    [Abstract] [Full Text] [Related]

  • 17. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.
    Tsitologiia; 2007 Feb 02; 49(10):889-900. PubMed ID: 18074781
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia.
    Roy S, Jørgensen HG, Roy P, Abed El Baky M, Melo JV, Strathdee G, Holyoake TL, Bartholomew C.
    Br J Haematol; 2012 May 02; 157(4):446-56. PubMed ID: 22372463
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
    Cashman JD, Eaves AC, Eaves CJ.
    Leukemia; 1992 Sep 02; 6(9):886-92. PubMed ID: 1518302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.